This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatologic Disorders  • Dermatologic Disorders, Other  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Successful Treatment of the Erythema and Flushing of Rosacea Using a Topically Applied Selective ₁-Adrenergic Receptor Agonist, Oxymetazoline

Stuart D. Shanler, MD; Andrew L. Ondo, MD

Arch Dermatol. 2007;143(11):1369-1371.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

The erythematotelangiectatic (ETR) subtype of rosacea is characterized by frequent episodes of facial flushing and persistent centrofacial erythema and may be accompanied by telangiectasias, facial edema, burning, or stinging. The pathophysiologic cause of the erythema is uncertain, and there are currently no satisfactory treatments for this common form of rosacea.

REPORT OF CASES

CASE 1

A 55-year-old man presented with a long history of ETR rosacea manifesting with prolonged facial flushing provoked by multiple stimuli including heat, exercise, sun exposure, and the consumption of alcoholic beverages. He confided that he was particularly disturbed that, for many years, people frequently asked him: "Why is your face so red?" His condition had progressed over the last 15 years to include persistent facial erythema. In addition to his usual triggers, he had noted that during his workday in an air conditioned office the erythema worsened, usually peaking in early afternoon, . . . [Full Text of this Article]

CASE 2

THERAPEUTIC CHALLENGE

SOLUTION

COMMENT

AUTHOR INFORMATION

School of Medicine, University of New Mexico, Albuquerque (Dr Ondo). Dr Shanler is in private practice in New York, New York.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?